- Home
- RVP vs NRXS Comparison
RVP vs NRXS Comparison
Compare RVP & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVP
- NRXS
- Stock Information
- Founded
- RVP 1994
- NRXS 2011
- Country
- RVP United States
- NRXS United States
- Employees
- RVP N/A
- NRXS N/A
- Industry
- RVP Medical/Dental Instruments
- NRXS
- Sector
- RVP Health Care
- NRXS
- Exchange
- RVP Nasdaq
- NRXS Nasdaq
- Market Cap
- RVP 25.1M
- NRXS 25.8M
- IPO Year
- RVP 2001
- NRXS 2023
- Fundamental
- Price
- RVP $0.98
- NRXS $3.08
- Analyst Decision
- RVP
- NRXS Strong Buy
- Analyst Count
- RVP 0
- NRXS 1
- Target Price
- RVP N/A
- NRXS $7.00
- AVG Volume (30 Days)
- RVP 77.3K
- NRXS 55.1K
- Earning Date
- RVP 11-13-2025
- NRXS 11-11-2025
- Dividend Yield
- RVP N/A
- NRXS N/A
- EPS Growth
- RVP N/A
- NRXS N/A
- EPS
- RVP N/A
- NRXS N/A
- Revenue
- RVP $38,161,712.00
- NRXS $3,217,531.00
- Revenue This Year
- RVP N/A
- NRXS $62.14
- Revenue Next Year
- RVP N/A
- NRXS $131.87
- P/E Ratio
- RVP N/A
- NRXS N/A
- Revenue Growth
- RVP N/A
- NRXS 41.93
- 52 Week Low
- RVP $0.56
- NRXS $1.33
- 52 Week High
- RVP $0.98
- NRXS $6.20
- Technical
- Relative Strength Index (RSI)
- RVP 80.71
- NRXS 60.58
- Support Level
- RVP $0.79
- NRXS $2.98
- Resistance Level
- RVP $0.98
- NRXS $3.24
- Average True Range (ATR)
- RVP 0.04
- NRXS 0.17
- MACD
- RVP 0.01
- NRXS 0.03
- Stochastic Oscillator
- RVP 98.28
- NRXS 68.75
About RVP Retractable Technologies Inc.
Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).